Piperacillin/tazobactam
Piperacillin/tazobactam is a pharmaceutical drug with 53 clinical trials. Currently 9 active trials ongoing. Historical success rate of 73.5%.
Success Metrics
Based on 25 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
9
Mid Stage
24
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
67.6%
25 of 37 finished
32.4%
12 ended early
9
trials recruiting
53
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Piperacillin/Tazobactam Versus ceftriAxone and Metronidazole for Children With Perforated Appendicitis (ALPACA)
Prophylactic Antibiotics in Preventing Surgical Site Infection After Hepatobiliary Surgery in High-Resistant Settings
Efficacy of Piperacillin-tazobactam as Empirical Antimicrobial Therapy for VAP Among ESBL-E Carriers.
Aminoglycosides in Early Sepsis
Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant
Clinical Trials (53)
Piperacillin/Tazobactam Versus ceftriAxone and Metronidazole for Children With Perforated Appendicitis (ALPACA)
Prophylactic Antibiotics in Preventing Surgical Site Infection After Hepatobiliary Surgery in High-Resistant Settings
Efficacy of Piperacillin-tazobactam as Empirical Antimicrobial Therapy for VAP Among ESBL-E Carriers.
Aminoglycosides in Early Sepsis
Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant
A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized Patients
Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)
Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?
PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)
Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis
Appropriateness of Antibiotic Combination Therapy for Severe Community-acquired Pneumonia in South Korea
PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic Shock
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
eXtended Antibiotic Prophylaxis for Intermediate- and High-risk Glands After Pancreatoduodenectomy to Reduce CR-POPF
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients
Model-based Dose Versus Empirical Dose of Piperacillin/Tazobactam in Preterm Neonates With Late-onset Sepsis.
Targeted AntiBiotics for Chronic Pulmonary Diseases
Ultra Low Doses of Therapy With Radiation Applicated to COVID-19
Pharmacokinetics of Antibiotics During Extracorporeal Membrane Oxygenation (ECMO) Support
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 53